c Urinary tract infections (UTIs) are the second most common bacterial infection. Urine culture is the gold standard for diagnosis, but new techniques, such as flow cytometry analysis (FCA), have been introduced. The aim of the present study was to evaluate FCA characteristics regarding bacteriuria, leukocyturia, and erythrocyturia in relation to cultured uropathogens in specimens from patients with a suspected UTI. We also wanted to evaluate whether the FCA characteristics can identify uropathogens prior to culture. From a prospective study, 1,587 consecutive urine specimens underwent FCA prior to culture during January and February 2012. Outpatients and inpatients (79.6% and 19.4%, respectively) were included, of whom women represented 67.5%. In total, 620 specimens yielded growth, of which Escherichia coli represented 65%, Enterococcus spp. 8%, Klebsiella spp. 7%, and Staphylococcus spp. 5%. For the uropathogens, the outcome of FCA was compared against the results for specimens with E. coli and those with a negative culture. E. coli had high bacterial (median, 17,914/l), leukocyte (median, 348/l), and erythrocyte (median, 23/l) counts. With the exception of Klebsiella spp., the majority of the uropathogens had considerable or significantly lower bacterial counts than that of E. coli. High leukocyte counts were found in specimens with Staphylococcus aureus, Proteus mirabilis, Pseudomonas aeruginosa, and group C streptococci. Elevated erythrocyte counts were found for P. vulgaris, P. aeruginosa, and group C streptococci, as well as for Staphylococcus saprophyticus. In essence, FCA adds new information about the bacterial, leukocyte, and erythrocyte counts in urine specimens for different uropathogens. Based on FCA characteristics, uropathogens can be classified and identified prior to culture. E. coli and Klebsiella spp. have similar FCA characteristics. U rinary tract infections (UTIs) are caused by pathogenic microorganisms in the urinary tract, causing an inflammatory response, as well as the presence of red and white blood cells in the urine. The inflammatory response and clinical manifestations depend on the etiologic organism, severity of infection, and immune status of the patient (1).UTIs are the second most common bacterial infection and are associated with high morbidity and costs. The annual incidence is estimated to be Ͼ175 million UTI episodes worldwide. In the United States, UTIs annually account for Ͼ7 million physician visits, Ͼ1 million emergency department visits, and Ͼ100,000 hospitalizations (2, 3).In outpatients, UTIs are the most frequent kind of bacterial infection, and antibiotics given for their treatment represent approximately 15% of all antibiotics prescribed to humans in the United States, with an estimated annual cost of Ͼ$1 billion (3). In addition, the indirect annual cost is estimated to be approximately $1.6 billion (4).The bacteria in urine can be classified as primary, secondary, tertiary, or doubtful uropathogens, according to their pathogenic capacity, frequency of appearan...